Blockchain-Based Pilot for Exchange of Clinical Data Announced by Grapevine World in Collaboration With the University of Southampton and Tiani Spirit

Food and Healthcare Press Releases Tuesday July 31, 2018 14:30
VIENNA--31 Jul--PRNewswire/InfoQuest

Grapevine World is a decentralized ecosystem for the seamless exchange and utilization of health data in a standardized, secure manner. In collaboration with the University of Southampton and Tiani Spirit, a new blockchain-enabled platform using the trusted Microsoft Azure cloud platform to track the provenance of healthcare data has been developed to break down data barriers and simplify the access and the ability to utilize health data for professionals.

The importance of medical data, its origins and quality have long been recognized in clinical research. Data provenance is the foundation of data quality, commonly implemented by automatically capturing the trace of data manipulation over space and time.

This pilot aims to demonstrate the value of combining market-proven interoperability standards in health data exchange (IHE) and blockchain technology (Hyperledger Fabric) for tracking and assessing health data provenance. The pilot will act as a trial run to assess the potential of the solution for clinical trial matching for one of Grapevine's early adopters, a Forbes 100 pharmaceutical corporation (requesting to remain unnamed at the time of the announcement).

"Following a successful pilot execution with our early adopter, we are excited to receive strong interest from multiple health and life science organisations to subsequently adopt our solution. Benefiting from Microsoft's global reach and strong support from the interoperability community, we meet a growing market need and will together overcome the current limitations for achieving a truly connected healthcare community," highlights Wernhard Berger, Chief Business Development Officer and Co-Founder of Grapevine World.

The "clinical trial matching" use case serves only as an initial launching pad for Grapevine's platform, which is designed to facilitate the consented data access for various types of organisations with a need for large-scale health data (universities, med- and biotech companies, etc.).

Powered by Azure, Grapevine can more easily overcome privacy, security, performance, and scalability challenges preventing many blockchain-based projects from reaching production stage, and limiting real-world adoption of the emergent technology in healthcare.

"Blockchain holds great potential for healthcare consortiums to collaborate to improve the quality of care, lower costs, and improve the experience of patients and healthcare workers. Powered by Microsoft Azure, Grapevine can overcome many of the challenges preventing many blockchain-based projects from reaching production stage, and limiting real-world adoption of this emergent technology in healthcare. Azure delivers industry-leading cloud-based security and compliance capabilities to empower healthcare consortiums to leverage blockchain to its full potential to help improve healthcare." David Houlding CISSP CIPP, Principal Healthcare Lead, Microsoft Azure.

Find more information about how this joint solution can benefit your organisation at   http://www.grapevineworldtoken.io/clinical-trial-pilot .
Contact: Kate Alippa,   kate@7marketzgroup.com   , +357-96545696
Source: Grapevine World

Latest Press Release

Global market of dietary supplement is welcoming a rising star GLYMATE

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,...

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent...

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with...

EVERSANA(TM) opens offices in Singapore Mumbai as Asia Pacific commercial business rapidly expands

EVERSANA(TM), the leading independent provider of global commercial services to the life science industry, today announced the rapid expansion of its Asia Pacific business with the addition of two new offices in Singapore and Mumbai. The announcement...

@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is...

Related Topics